Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging... Show more
The Stochastic Oscillator for BIOA moved into overbought territory on June 13, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on May 29, 2025. You may want to consider a long position or call options on BIOA as a result. In of 11 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BIOA just turned positive on June 02, 2025. Looking at past instances where BIOA's MACD turned positive, the stock continued to rise in of 3 cases over the following month. The odds of a continued upward trend are .
BIOA moved above its 50-day moving average on May 22, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BIOA advanced for three days, in of 36 cases, the price rose further within the following month. The odds of a continued upward trend are .
A.I.dvisor indicates that over the last year, BIOA has been loosely correlated with NNOMF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BIOA jumps, then NNOMF could also see price increases.
Ticker / NAME | Correlation To BIOA | 1D Price Change % | ||
---|---|---|---|---|
BIOA | 100% | +0.67% | ||
NNOMF - BIOA | 43% Loosely correlated | -6.04% | ||
CSNVY - BIOA | 31% Poorly correlated | N/A | ||
PPG - BIOA | 26% Poorly correlated | -5.11% | ||
NDEKF - BIOA | 25% Poorly correlated | N/A | ||
AKZOY - BIOA | 23% Poorly correlated | -3.20% | ||
More |